XML 55 R2.htm IDEA: XBRL DOCUMENT v3.24.1
Pay vs Performance Disclosure - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Pay vs Performance Disclosure        
Pay vs Performance Disclosure, Table
 
Pay versus Performance
The following table sets forth certain information with respect to the Company’s financial performance and the compensation paid to our NEOs for the fiscal years (“FY”) ended on December 31, 2023, December 31, 2022, December 31, 2021 and December 31, 2020, as required by SEC rules.
 
               
Year
Summary
Compensation
Table Total for
PEO
(1)
($)
Compensation
Actually Paid to
PEO
(1)(2)(7)
($)
Average
Summary
Compensation
Table Total for
non-PEO

NEOs
(3)
($)
Average
Compensation
Actually Paid
to
non-PEO

NEOs
(2)(3)(7)
($)
Value of initial fixed $100
Investment based on:
Net
Income
($mm)
(5)
Adjusted
EPS
(6)
($)
Total
Shareholder
Return
(4)
($)
Peer Group
Total
Shareholder
Return
(4)
($)
               
2023
 $ 8,389,910 $ 2,434,260   $ 3,274,168 $ 2,596,315 $ 373 $ 123 ($ 41 ) $ 1.36
               
2022
   6,245,259   (20,486,138 )   2,782,307   (1,231,650 )   378   117   22   2.42
               
2021
   7,680,578   42,840,278     3,378,068   7,915,780     843   151   222   4.10
               
2020
   7,628,179   56,613,156   2,277,468   8,482,353   524   125   30   2.26
 
(1)
The name of the Principal Executive Officer of the Company (“PEO”) reflected in these columns for each of the applicable fiscal years is Edward A. Pesicka.
 
(2)
In calculating the ‘compensation actually paid’ (“CAP”) amounts reflected in these columns, the fair value or change in fair value, as applicable, of the equity award adjustments included in such calculations was computed in accordance with FASB ASC Topic 718. The valuation assumptions used to calculate such fair values did not materially differ from those disclosed at the time of grant (except for changes due to the relevant measurement date).
 
(3)
The names of each of the
non-PEO
NEOs reflected in these columns for each applicable fiscal year are as follows: (i) for fiscal year 2023, Andrew G. Long, Alexander J. Bruni, Perry A. Bernocchi, and Daniel J. Starck; (ii) for fiscal year 2022, Mr. Long, Mr. Bruni, Nicholas J. Pace, Mr. Starck, Tammy L. Gomez and Jeffrey T. Jochims; (iii) for fiscal year 2021, Mr. Long, Mr. Jochims, Christopher M. Lowery, Mr. Pace and Mark P. Zacur; and (iv) for fiscal year 2020, Mr. Long, Mr. Jochims and Mr. Lowery.
 
(4)
The Company TSR and the Company’s Peer Group TSR reflected in these columns for each applicable fiscal year is calculated based on a fixed investment of $100 at the applicable measurement point on the same cumulative basis as is used in Item 201(e) of Regulation
S-K.
 
 
The peer group used to determine the Company’s Peer Group TSR for each applicable fiscal year is the following published industry index, as disclosed in our 2024 Annual Report on Form
10-K
pursuant to Item 201(e) of Regulation
S-K:
Russell 3000 Medical Equipment and Services Sector Index.
 
(5)
Represents the amount of net income reflected in the Company’s audited financial statements for each
applicable
fiscal year.
 
(6)
We have selected Adjusted EPS as our most important financial measure (that is not otherwise required to be disclosed in the table) used to link CAP to our NEOs to company performance for fiscal year 2023. Adjusted EPS is a
non-GAAP
financial measure, which excludes items and charges that (i) management does not believe reflect the Company’s core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred without predictable trends from net income reported in accordance with U.S. GAAP. Charges excluded from Adjusted EPS and other
non-GAAP
financial measures include intangible amortization, acquisition-related and exit and realignment charges, and other adjustments. Adjusted EPS and other
non-GAAP
financial measures included in this Proxy Statement and a reconciliation to the most comparable GAAP equivalent financial measure for the years ended December 31, 2023, 2022, 2021, and 2020 are described in the Company’s Current Reports on Form
8-K
filed with the SEC on February 20, 2024, February 28, 2023 and February 23, 2022.
 
(7)
For fiscal years 2023, 2022, 2021 and 2020 the CAP to the PEO and the average CAP to the
non-PEO
NEOs reflect the following adjustments made to the total compensation amounts reported in the Summary Compensation Table for fiscal years 2023, 2022, 2021 and 2020, as applicable, computed in accordance with Item 402(v) of Regulation
S-K.
Adjustments for (a) increase in fair value of awards granted and vesting during the applicable FY, and (b) reduction of fair value of awards granted during prior FY that were forfeited during the applicable FY, were not included as columns because there were no values to report during the covered year:
             
Year
Deduction for
amounts
reported in the
“Stock Awards”
and “Option
Awards”
columns in the
SCT for
applicable FY
Increase in fair
value of awards
granted during
applicable FY
that remain
unvested as of
applicable FY
end, determined
as of applicable
FY end
Change in fair
value of awards
granted during
prior FY that
were outstanding
and unvested as
of applicable FY
end, determined
based on change
in fair value from
prior FY end to
applicable FY end
Change in fair
value of awards
granted during
prior FY that
vested during
applicable FY,
determined
based on change
in fair value from
prior FY end to
vesting date
Increase based
on dividends or
other earnings
paid during
applicable FY
prior to vesting
date
Total
Adjustments
           
PEO
           
2023
 $ (5,834,851 )   $4,084,966   $(49,069 )  $ (4,156,695 )   —   $(5,955,649 ) 
           
2022
   (4,915,897 )   1,141,587   (21,056,470 )   (1,903,417 )   2,800   (26,731,397 )
           
2021
   (4,400,000 )   8,409,551   29,692,842   1,440,780   16,527   35,159,700
           
2020
   (4,400,000 )   24,624,886   28,689,464   64,068   6,559   48,984,977
           
Avg.
non-PEO
NEOs
           
2023
 $ (2,086,665 )   $1,597,860   $(11,257 )    $(177,791 )    —   $(677,853 ) 
           
2022
   (1,950,021 )   378,830   (2,249,301 )   (193,567 )   103   (4,013,956 )
           
2021
   (1,700,000 )   2,841,429   2,961,055   433,444   1,784   4,537,712
           
2020
   (733,333 )   4,104,161   2,573,437   259,703   918   6,204,886
     
Company Selected Measure Name Adjusted EPS      
Named Executive Officers, Footnote The names of each of the
non-PEO
NEOs reflected in these columns for each applicable fiscal year are as follows: (i) for fiscal year 2023, Andrew G. Long, Alexander J. Bruni, Perry A. Bernocchi, and Daniel J. Starck; (ii) for fiscal year 2022, Mr. Long, Mr. Bruni, Nicholas J. Pace, Mr. Starck, Tammy L. Gomez and Jeffrey T. Jochims; (iii) for fiscal year 2021, Mr. Long, Mr. Jochims, Christopher M. Lowery, Mr. Pace and Mark P. Zacur; and (iv) for fiscal year 2020, Mr. Long, Mr. Jochims and Mr. Lowery. 		     
Peer Group Issuers, Footnote
(4)
The Company TSR and the Company’s Peer Group TSR reflected in these columns for each applicable fiscal year is calculated based on a fixed investment of $100 at the applicable measurement point on the same cumulative basis as is used in Item 201(e) of Regulation
S-K.
 
 
The peer group used to determine the Company’s Peer Group TSR for each applicable fiscal year is the following published industry index, as disclosed in our 2024 Annual Report on Form
10-K
pursuant to Item 201(e) of Regulation
S-K:
Russell 3000 Medical Equipment and Services Sector Index.
     
PEO Total Compensation Amount $ 8,389,910 $ 6,245,259 $ 7,680,578 $ 7,628,179
PEO Actually Paid Compensation Amount $ 2,434,260 (20,486,138) 42,840,278 56,613,156
Adjustment To PEO Compensation, Footnote
             
Year
Deduction for
amounts
reported in the
“Stock Awards”
and “Option
Awards”
columns in the
SCT for
applicable FY
Increase in fair
value of awards
granted during
applicable FY
that remain
unvested as of
applicable FY
end, determined
as of applicable
FY end
Change in fair
value of awards
granted during
prior FY that
were outstanding
and unvested as
of applicable FY
end, determined
based on change
in fair value from
prior FY end to
applicable FY end
Change in fair
value of awards
granted during
prior FY that
vested during
applicable FY,
determined
based on change
in fair value from
prior FY end to
vesting date
Increase based
on dividends or
other earnings
paid during
applicable FY
prior to vesting
date
Total
Adjustments
           
PEO
           
2023
 $ (5,834,851 )   $4,084,966   $(49,069 )  $ (4,156,695 )   —   $(5,955,649 ) 
           
2022
   (4,915,897 )   1,141,587   (21,056,470 )   (1,903,417 )   2,800   (26,731,397 )
           
2021
   (4,400,000 )   8,409,551   29,692,842   1,440,780   16,527   35,159,700
           
2020
   (4,400,000 )   24,624,886   28,689,464   64,068   6,559   48,984,977
           
Avg.
non-PEO
NEOs
           
2023
 $ (2,086,665 )   $1,597,860   $(11,257 )    $(177,791 )    —   $(677,853 ) 
           
2022
   (1,950,021 )   378,830   (2,249,301 )   (193,567 )   103   (4,013,956 )
           
2021
   (1,700,000 )   2,841,429   2,961,055   433,444   1,784   4,537,712
           
2020
   (733,333 )   4,104,161   2,573,437   259,703   918   6,204,886
     
Non-PEO NEO Average Total Compensation Amount $ 3,274,168 2,782,307 3,378,068 2,277,468
Non-PEO NEO Average Compensation Actually Paid Amount $ 2,596,315 (1,231,650) 7,915,780 8,482,353
Adjustment to Non-PEO NEO Compensation Footnote
             
Year
Deduction for
amounts
reported in the
“Stock Awards”
and “Option
Awards”
columns in the
SCT for
applicable FY
Increase in fair
value of awards
granted during
applicable FY
that remain
unvested as of
applicable FY
end, determined
as of applicable
FY end
Change in fair
value of awards
granted during
prior FY that
were outstanding
and unvested as
of applicable FY
end, determined
based on change
in fair value from
prior FY end to
applicable FY end
Change in fair
value of awards
granted during
prior FY that
vested during
applicable FY,
determined
based on change
in fair value from
prior FY end to
vesting date
Increase based
on dividends or
other earnings
paid during
applicable FY
prior to vesting
date
Total
Adjustments
           
PEO
           
2023
 $ (5,834,851 )   $4,084,966   $(49,069 )  $ (4,156,695 )   —   $(5,955,649 ) 
           
2022
   (4,915,897 )   1,141,587   (21,056,470 )   (1,903,417 )   2,800   (26,731,397 )
           
2021
   (4,400,000 )   8,409,551   29,692,842   1,440,780   16,527   35,159,700
           
2020
   (4,400,000 )   24,624,886   28,689,464   64,068   6,559   48,984,977
           
Avg.
non-PEO
NEOs
           
2023
 $ (2,086,665 )   $1,597,860   $(11,257 )    $(177,791 )    —   $(677,853 ) 
           
2022
   (1,950,021 )   378,830   (2,249,301 )   (193,567 )   103   (4,013,956 )
           
2021
   (1,700,000 )   2,841,429   2,961,055   433,444   1,784   4,537,712
           
2020
   (733,333 )   4,104,161   2,573,437   259,703   918   6,204,886
     
Compensation Actually Paid vs. Total Shareholder Return
LOGO
     
Compensation Actually Paid vs. Net Income
LOGO
     
Compensation Actually Paid vs. Company Selected Measure
LOGO
     
Total Shareholder Return Vs Peer Group
LOGO
     
Tabular List, Table
Pay versus Performance Tabular List
The following table lists our most important performance measures used by us to link CAP to our NEOs to company performance for fiscal year 2023. The performance measures included in this table are not ranked by relative importance.
 
 
Most Important
Performance
Measures
Adjusted EPS
Revenue
Adjusted Operating
Income
      
Total Shareholder Return Amount $ 373 378 843 524
Peer Group Total Shareholder Return Amount 123 117 151 125
Net Income (Loss) $ (41,000,000) $ 22,000,000 $ 222,000,000 $ 30,000,000
Company Selected Measure Amount 1.36 2.42 4.1 2.26
PEO Name Edward A. Pesicka      
Measure:: 1        
Pay vs Performance Disclosure        
Name Adjusted EPS      
Non-GAAP Measure Description We have selected Adjusted EPS as our most important financial measure (that is not otherwise required to be disclosed in the table) used to link CAP to our NEOs to company performance for fiscal year 2023. Adjusted EPS is a
non-GAAP
financial measure, which excludes items and charges that (i) management does not believe reflect the Company’s core business and relate more to strategic, multi-year corporate activities; or (ii) relate to activities or actions that may have occurred without predictable trends from net income reported in accordance with U.S. GAAP. Charges excluded from Adjusted EPS and other
non-GAAP
financial measures include intangible amortization, acquisition-related and exit and realignment charges, and other adjustments. Adjusted EPS and other
non-GAAP
financial measures included in this Proxy Statement and a reconciliation to the most comparable GAAP equivalent financial measure for the years ended December 31, 2023, 2022, 2021, and 2020 are described in the Company’s Current Reports on Form
8-K
filed with the SEC on February 20, 2024, February 28, 2023 and February 23, 2022. 		     
Measure:: 2        
Pay vs Performance Disclosure        
Name Revenue      
Measure:: 3        
Pay vs Performance Disclosure        
Name Adjusted OperatingIncome      
PEO        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ (5,955,649) $ (26,731,397) $ 35,159,700 $ 48,984,977
PEO | Increase In Fair Value Of Awards Granted During Applicable Fy That Remain Unvested As Of Applicable Fyend, Determined As Of Applicable Fy End [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 4,084,966 1,141,587 8,409,551 24,624,886
PEO | Change In Fair Value Of Awards Granted During Prior Fy That Were Outstanding And Unvested As Of Applicable Fy End, Determined Based On Change In Fair Value From Prior Fy End To Applicable Fy End [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (49,069) (21,056,470) 29,692,842 28,689,464
PEO | Change In Fair Value Of Awards Granted During Prior Fy That Vested During Applicable Fy, Determined Based On Change In Fair Value From Prior Fy End To Vesting Date [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (4,156,695) (1,903,417) 1,440,780 64,068
PEO | Increase Based On Dividends Or Other Earnings Paid During Applicable Fy Prior To Vesting Date [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 0 2,800 16,527 6,559
PEO | OMI Deduction For Amounts Reported In Thestock Awards Andoption Awards Columns In The Sct For Applicable Fy [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (5,834,851) (4,915,897) (4,400,000) (4,400,000)
Non-PEO NEO        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (677,853) (4,013,956) 4,537,712 6,204,886
Non-PEO NEO | Deduction For Amounts Reported In The Stock Awards And Option Awards Columns In The Sct For Applicable Fy [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (2,086,665) (1,950,021) (1,700,000) (733,333)
Non-PEO NEO | Increase In Fair Value Of Awards Granted During Applicable Fy That Remain Unvested As Of Applicable Fyend, Determined As Of Applicable Fy End [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount 1,597,860 378,830 2,841,429 4,104,161
Non-PEO NEO | Change In Fair Value Of Awards Granted During Prior Fy That Were Outstanding And Unvested As Of Applicable Fy End, Determined Based On Change In Fair Value From Prior Fy End To Applicable Fy End [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (11,257) (2,249,301) 2,961,055 2,573,437
Non-PEO NEO | Change In Fair Value Of Awards Granted During Prior Fy That Vested During Applicable Fy, Determined Based On Change In Fair Value From Prior Fy End To Vesting Date [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount (177,791) (193,567) 433,444 259,703
Non-PEO NEO | Increase Based On Dividends Or Other Earnings Paid During Applicable Fy Prior To Vesting Date [Member]        
Pay vs Performance Disclosure        
Adjustment to Compensation, Amount $ 0 $ 103 $ 1,784 $ 918